Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8
Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Helena Castillo‐Ecija(Hospital Sant Joan de Déu Barcelona), Maria Cuadrado‐Vilanova(Hospital Sant Joan de Déu Barcelona), Nataliya Kuplennik(Technion – Israel Institute of Technology), Cinzia Lavarino, Alejandro Sosnik(Technion – Israel Institute of Technology), Mònica Vilà-Ubach(Hospital Sant Joan de Déu Barcelona), Sonia Paco(Hospital Sant Joan de Déu Barcelona), Jaume Mora(Hospital Sant Joan de Déu Barcelona), Guillem Pascual‐Pasto(Children's Hospital of Philadelphia), Nagore G. Olaciregui(Sant Joan de Déu Research Foundation), Romina J. Glisoni(Consejo Nacional de Investigaciones Científicas y Técnicas), Carmen de Torres(Centro de Diseño, Arquitectura y Construcción), N K Cheung(Memorial Sloan Kettering Cancer Center), Achim A. Jungbluth(Gynecologic Oncology Group), M. Mar Ferrandiz(Hospital Sant Joan de Déu Barcelona)
Cited by 47
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
|New England Journal of Medicine|2008|903